Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FUJMA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for NUCALA 100 mg/ml auto-injectors. The delivery order, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a firm fixed-price contract with no set-aside designation. This award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group operates as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively for government contracts. The company's PPV-G GEN V contract, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. Through this prime vendor arrangement, DMS Pharmaceutical Group is authorized to supply a broad portfolio of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FUJMA?
SPE2DB26FUJMA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FUJMA worth?
The government has obligated $3,786 on SPE2DB26FUJMA.
Is contract SPE2DB26FUJMA an order under another contract?
Yes. SPE2DB26FUJMA is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB26FUJMA competed?
The extent of competition for SPE2DB26FUJMA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award